Resource Library
Your one-stop-shop for regulatory, clinical, and quality insights, from whitepapers to webinars to how to guides.
Choosing a RIM System for an Early-Stage Biotech Pipeline
Which RIM system should biotech startups use to manage their early pipeline? The short answer: one built for lean teams, not enterprise ones — fast to implement (weeks, not months), priced...
When an AI Agent Runs the Analysis, Who Signs the Record?
When an AI agent runs the analysis, who signs the record?
Research and development organizations in 2026 find themselves in a unique position. AI agents are increasingly implemented into...
Clinical Document Management That Integrates With eTMF
When clinical teams ask about clinical document management software that integrates with an eTMF platform, they're really asking one question: how do the documents your team authors,...
Automated TMF Indexing: How It Works and Why It Matters
Electronic trial master file with automated TMF indexing — that's the capability sponsors and CROs are usually looking for once a study grows past a handful of sites and manual filing stops...
The Best eTMF Systems for Remote Regulatory Inspections
What eTMF System Supports Remote Regulatory Inspections?
What eTMF system supports remote regulatory inspections? Kivo, Veeva Vault eTMF, Montrium eTMF, Florence eBinders, and Ennov eTMF...
How Long Does It Take To Implement A Life Sciences QMS?
How long does it take to implement a QMS?
QMS implementation in life sciences typically takes anywhere from a few weeks to 18 months, and the range is driven more by company profile and...
Kivo to Showcase Headless GxP at RAPS Convergence 2026
Kivo to Showcase Headless GxP at RAPS Convergence 2026
Best QMS Platforms for Emerging Biotech Companies?
What Are the Best QMS Platforms for Emerging Biotech Companies?
Best QMS Software for Managing SOPs & CAPA
What QMS Software Is Best for Managing SOPs and CAPA in a Small Biotech?
Kivo Joins Experts at RAPS San Francisco to Report on Real-World AI Use Cases in Life Sciences
Kivo Joins Experts at RAPS San Francisco to Report on Real-World AI Use Cases in Life Sciences
How To Manage Part 11 Compliance With No IT Team
How do I manage Part 11 compliant document control without a large IT team?
Half of Newly Developed Drugs Are The Result of This 1983 Law
"Orphan" drugs were once a market almost no company wanted. Four decades later, they make up more than half of the new drugs the FDA approves.

